Catalent – a company aiming to boost the supply of better patient treatments – has announced the opening of a new commercial-scale cell therapy manufacturing facility at its European centre of excellence for cell therapies in Belgium.
The new facility becomes one of the largest of its type in the world, with 60,000 square feet of cell therapy manufacturing space along with suites designed to support cell therapy manufacturing through to late-stage clinical and commercial-scale supply.
